William R. Bartle

Sunnybrook Health Science Centre — Canada

Medicine · Health Sciences

11h-index506citations32works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pharmaceutical Practices and Patient Outcomes(6), Pharmacogenetics and Drug Metabolism(5), Venous Thromboembolism Diagnosis and Management(4), Drug-Induced Hepatotoxicity and Protection(4), Vitamin K Research Studies(4)

Publications32 total

Analysis of Real-World Experiences with the Ontario MedsCheck Program
The Canadian Journal of Hospital Pharmacy·2019· 1 citedOpen Access
Quality Concerns of Over-the-Counter Vitamin K Supplements
Annals of Pharmacotherapy·2013· 2 cited
Patient Information About Warfarin: An Assessment of Accuracy and Readability
JAMA Internal Medicine·2013· 14 cited
Phylloquinone, MK‐4 and MK‐7 contents of some commercially available oral supplements
The FASEB Journal·2010
Extended Dalteparin Prophylaxis for Venous Thromboembolic Events
American Journal of Cardiovascular Drugs·2009· 12 cited
Extended dalteparin prophylaxis for venous thromboembolic events: cost-utility analysis in patients undergoing major orthopedic surgery.
PubMed·2009· 11 cited
Fellowship in Medical Editing
The Canadian Journal of Hospital Pharmacy·2004
Warfarin in the Secondary Prevention of Thromboembolism in Atrial Fibrillation
PharmacoEconomics·2004· 10 cited
A Brief History of Medicare in Canada
The Canadian Journal of Hospital Pharmacy·2003
La thrombose veineuse et le pharmacien
The Canadian Journal of Hospital Pharmacy·2002
Venous Thrombosis and the Pharmacist
The Canadian Journal of Hospital Pharmacy·2002· 1 cited
The Most Invisible Part of Health Care
The Canadian Journal of Hospital Pharmacy·2001
La face la plus cachée de la santé
The Canadian Journal of Hospital Pharmacy·2001
The Helicobacter pylori Handbook
The Canadian Journal of Hospital Pharmacy·2000
The Effects of Acetaminophen on Pharmacokinetics and Pharmacodynamics of Warfarin
The Journal of Clinical Pharmacology·1999· 59 cited
Cost Considerations in the Pharmacological Prevention and Treatment of Stroke
PharmacoEconomics·1997· 7 cited
Serum Concentrations of Salicylic Acid following Topically Applied Salicylate Derivatives
Annals of Pharmacotherapy·1996· 68 cited
Abnormal serum transaminases following therapeutic doses of acetaminophen in the absence of known risk factors
Digestive Diseases and Sciences·1995· 46 cited
Drugs in Gastroenterology
The Canadian Journal of Hospital Pharmacy·1993
Drug interactions with warfarin
The Medical Journal of Australia·1993· 4 cited
page 1 of 2Next →

Frequent Co-authors

Scott E. Walker(6), Debora Kwan(3), William Geerts(3), Artemis Diamantouros(2), George Dranitsaris(2), Carmine Stumpo(2), Reginald E. Smith(2), Paul Oh(2), Guylaine Ferland(2), Ina Sungaila(1), Carlo DeAngelis(1), Jack Uetrecht(1), Chris Pappas(1), E.I. Vidins(1), Pina Morra(1), Sangyoung Lee(1), Susan K. Bowles(1), Richard A. Reeves(1), Robert M. Walter(1), Brian G. Hardy(1)